Smart dosing could transform Crohn's treatment in kids
NCT ID NCT05660746
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a computer program that calculates a personalized dose of infliximab based on blood tests can help children with Crohn's disease achieve deep remission better than standard dosing. About 180 children and young adults (ages 6โ22) newly diagnosed with Crohn's will take part. The goal is to see if precision dosing leads to fewer symptoms and healed intestines without the need for steroids.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Los Angeles
RECRUITINGLos Angeles, California, 90027, United States
-
Children's Specialty Group
RECRUITINGNorfolk, Virginia, 23507, United States
-
Cincinnati Children's Hospital
RECRUITINGCincinnati, Ohio, 45229, United States
-
Cleveland Clinic Children's Hospital
RECRUITINGCleveland, Ohio, 44106, United States
-
Lucile Packard Children's Hospital Stanford
RECRUITINGPalo Alto, California, 94304, United States
-
Medical College of Wisconsin, Children's of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Nationwide Children's Hospital
RECRUITINGColumbus, Ohio, 43205, United States
-
Nemours Children's Health System-Jacksonville
RECRUITINGJacksonville, Florida, 32207, United States
-
Nemours Children's Health System-Wilmington
RECRUITINGWilmington, Delaware, 19803, United States
-
Rady Children's Hospital San Diego
RECRUITINGSan Diego, California, 92123, United States
-
Riley Hospital for Children
RECRUITINGIndianapolis, Indiana, 46202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a patient registry unlock the secrets of IBD?
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Can a Real-World study reveal the staying power of guselkumab?